Skip to main content
ConductScienceScienceDex

Marlene Rabinovitch

NIH Rank #1806
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2413447Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Genetics
  • Pediatrics

NIH Funding · FY2025

Linked Award Amount
$4.3M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#1,806
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Marlene Rabinovitch. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Marlene Rabinovitch as a PI. Multi-PI records show the full award amount for context.

  • 1UG3HL180990-01UG3
    1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Stanford University
    $2M
    award amount
  • 5R01HL171609-02R01
    Mapping, programming, and correcting gene regulatory sequences for Alagille Syndrome
    Stanford University
    $761.9K
    award amount
  • 5R01HL138473-06R01
    BMPR2, Monocytes and Macrophages in Pulmonary Artery Hypertension
    Stanford University
    $645.7K
    award amount
  • 1P01HL180323-01P01
    Identifying causal gene programs for vascular disease using high throughput CRISPR genomics
    Stanford University
    $516.1K
    award amount
  • 2R38HL143615-05A1R38
    Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
    Stanford University
    $401K
    award amount

Award organization

Organizations that administered FY2025 awards listing Marlene Rabinovitch as a PI.

FY2025 award administered by Stanford University (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Stanford University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4617
  6. 2024
    Entered Top 25% Nationally
    Ranked #4617
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Entered Top 10% Nationally
    Ranked #1806
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Marlene Rabinovitch.

Jesse M Engreitz
Stanford University
5
shared awards
Mark Robert Nicolls
Stanford University
3
shared awards
Rajat M Gupta
Stanford University
2
shared awards
Thomas Quertermous
Stanford University
2
shared awards
Joseph C. Wu
Stanford University
1
shared award
Michael Peter Fischbein
Stanford University
1
shared award
Roham Zamanian
Stanford University
1
shared award

Explore further

Find collaborators for Marlene Rabinovitch

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →